vimarsana.com

Latest Breaking News On - Inmune bio aktie - Page 1 : vimarsana.com

INmune Bio Inc to Report Fourth Quarter 2023 Financial Results and Provide a Corporate Update on Thursday, March 28

26.03.2024 - Management to host conference call and webcast at 4:30 pm ET on that day Boca Raton, Florida, March 26, 2024 (GLOBE NEWSWIRE) - INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology and inflammation company focused . Seite 1

INmune Bio to Participate in Baird s Biotech Discovery Series Webcast on February 13, 2024 Seite 1

06.02.2024 - Boca Raton, Florida, Feb. 06, 2024 (GLOBE NEWSWIRE) -  INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company targeting microglial activation and neuroinflammation as a cause of Alzheimer’s disease (AD) with XProTM . Seite 1

INmune Bio Announces First Patient Dosed in a Phase 1/2 Study of INKmune in Patients with Metastatic Castration-Resistant Prostate Cancer

02.01.2024 - Boca Raton, Florida, Jan. 02, 2024 (GLOBE NEWSWIRE) -  INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight  disease, dosed . Seite 1

Inmune Bio: Was sagt man dazu? () | aktiencheck de

Inmune Bio: Was sagt man dazu? () | aktiencheck de
aktiencheck.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aktiencheck.de Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.